About iCardiac Technologies, Inc.

iCardiac Technologies performs advanced research studies that help pharmaceutical companies and regulators determine if new medicines that are being developed may potentially have lethal cardiac side effects. Built upon many years of research at the University of Rochester and at Pfizer, iCardiac is a recognized scientific leader in cardiac safety assessment. iCardiac works with 8 of the largest 10 pharmaceutical companies in the world, as well as with many smaller pharma and biotech companies.

What employees say

“I am respected here and treated well.”
“The team is amazing. Things get done.”
“We are making a difference in drug development. ”
Where to find iCardiac Technologies, Inc.